KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight
Gydesen, Sofie, Andreassen, Kim Vietz, Hjuler, Sara Toftegaard, Christensen, Jane Marie, Karsdal, Morten Asser, Henriksen, KimVolume:
310
Language:
english
Journal:
American Journal of Physiology - Endocrinology And Metabolism
DOI:
10.1152/ajpendo.00514.2015
Date:
May, 2016
File:
PDF, 1.79 MB
english, 2016